Researchers at DTU Biosustain (The Novo Nordisk Foundation Center for Biosustainability at DTU) have developed a new tool ...

With the current market volatility, knowing which biotech stocks to buy on the dip can lead to lucrative returns as the industry is likely to recover faster than the market average. After all ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

Sana is Incorporating the Tested Immune Evasion Technology to Develop SC451, a HIP-modified, Stem Cell-Derived Therapy as a One-Time Treatment for Patients with Type 1 Diabetes, with a Goal of Normal ...

The company plans to submit efsitora, its once-weekly insulin for type 2 diabetes, to global regulators by end-2026 following ...

Shares of Sana Biotechnology jumped after the company reported positive results for the latest study transplanting its UP421 cell therapy into a patient with type 1 diabetes. The stock was up 21% at ...

Sydney-based biotech company All G affirmed the GRAS status of its recombinant ... Biotech-derived insulin went from “zero market share in 10 years to 99% market share,” demonstrating how ...

This week, STAT's The Readout Loud podcast discusses Donald Trump running mate JD Vance's health care investments, insulin shortages as drugmakers focus on GLP-1s, and more.

William Rutter and biochemistry professor Pablo D. T. Valenzuela, Ph.D., create the biotech firm Chiron Corporation. The company becomes the first to map the DNA structure of HIV and produce the world ...

With the current market volatility, knowing which biotech stocks to buy on the dip can lead to lucrative returns as the industry is likely to recover faster than the market average. After all ...